Powered by
iCo Therapeutics soars 14.3% March 01, 2017 17:00 EST
Mar 1, 2017 - News Bites Canadian Markets

CANADIAN DAILY STOCK REPORT

iCo Therapeutics Inc. (TSXV:ICO), Canada's 51st largest Biotechnology company by market cap, has soared 0.50c (14.3%) from its last trading session of February 28 to close at 4.0c. Compared with the S&P/TSX 60 Index which rose 11.1 points (1.2%) in the day, the relative price increase was 13.1%. The volume was 0.1 times the average daily trading volume of 416,575 shares.

SECTION 1

ICO THERAPEUTICS BULLISH SIGNALS

1.1 Fundamentals:

+ T

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 10 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox